[1]RSCAdvances,2019,vol.9,p.28886-28893
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
7073-42-9 | 3-Chloro-4-Methoxyacetanilide | AA00FD6M | MFCD00157588
697287-48-2 | (E)-3-(2-Fluorophenyl)-N-((S)-1-(3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]acrylamide | AA00FDDT | MFCD09753840
74509-14-1 | 2-formyl-5-(hydroxymethyl)pyrrole-1-norleucine | AA00FDMJ | MFCD12408091
71595-19-2 | tolmetin glucuronide | AA00FDT3 | MFCD28899111
668970-91-0 | 4-Ethynyl-3,5-dimethylisoxazole | AA00FE31 | MFCD08703589
690646-10-7 | 3-([(3-FLUOROPHENYL)SULFONYL]AMINO)PROPANOIC ACID | AA00FEJB | MFCD05741683
6843-45-4 | 3-Methylimidazolidine-2,4-dione | AA00FF9Z | MFCD12755958
685508-28-5 | Cis-2-benzyloxycarbonylaminocyclobutanecarboxylic acid | AA00FFR9 | MFCD03844615
696-80-0 | Pyrimidine, 2,4-difluoro-6-methyl- (7CI,8CI,9CI) | AA00FG0C | MFCD18377655
741288-57-3 | 1,3,3-Trimethylpiperazine | AA00FGE3 | MFCD09971198